Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Definitive Healthcare Corp (DH)
NASDAQ:DH
Holding DH?
Track your performance easily
Earnings Data
Report Date
Feb 20, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
$0.07Last Year’s EPS
$0.07Same Quarter Last Year
Moderate Buy
Based on 7 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 07, 2024
|% Change Since: -3.02%
|Next Earnings Date:Feb 20, 2025
Earnings Call Sentiment|Neutral
The earnings call reflected a mixed sentiment with achievements in exceeding some financial guidance and product innovation. However, the company faced significant challenges with revenue decline, elevated churn rates, and leadership changes, affecting the overall outlook.Company Guidance
During Definitive Healthcare's Q3 2024 earnings call, the company provided guidance indicating a sequential decline in revenue for Q4 2024 and into early 2025, with expectations to return to sequential revenue growth in the second half of 2025. The company reported Q3 revenue of $62.7 million, a 4% year-over-year decrease, and adjusted EBITDA of $20.6 million, down 5% year-over-year. Despite these declines, the adjusted EBITDA margin remained at 33% due to cost discipline. Definitive Healthcare expects Q4 2024 revenue to be between $60 million and $61 million, representing a 7% to 9% decrease compared to Q4 2023, and projects a full-year net dollar retention (NDR) rate of 85% to 87%. The company also announced a $100 million share buyback program, reflecting confidence in its long-term prospects and commitment to enhancing shareholder value.Revenue and Growth Metrics
Total revenue for Q3 was $62.7 million, slightly down 4% year-over-year but above the high end of guidance. Renewal rates improved year-over-year.
Adjusted EBITDA Performance
Adjusted EBITDA was $20.6 million, down 5% year-over-year, with a margin of 33%, consistent with the prior year despite revenue decline.
Product Innovations
Introduced two new product enhancements in Q3: Market Forecast and Monocl Conferences, aimed at improving customer value proposition.
Share Buyback Program
The Board approved a $100 million expansion of the share buyback program, showing confidence in long-term prospects and strong cash flow generation.
Free Cash Flow
Generated $24.3 million of unlevered free cash flow in Q3 and $85.2 million on a trailing 12-month basis, up 58% year-over-year.
---
DH Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
DH Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 07, 2024 | $4.31 | $4.24 | -1.62% |
| Aug 05, 2024 | $3.55 | $3.65 | +2.82% |
| May 07, 2024 | $7.25 | $5.35 | -26.21% |
| Feb 28, 2024 | $9.20 | $9.52 | +3.48% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Definitive Healthcare Corp (DH) report earnings?
Definitive Healthcare Corp (DH) is schdueled to report earning on Feb 20, 2025, TBA Not Confirmed.
What is Definitive Healthcare Corp (DH) earnings time?
Definitive Healthcare Corp (DH) earnings time is at Feb 20, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is DH EPS forecast?
DH EPS forecast for the fiscal quarter 2024 (Q4) is $0.07.
---